CIK 0000875045
- Large accelerated filer
BIOGEN INC.
Sign in to watch- Ticker
- BIIB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330112644
- Phone
- +1 617-679-2000
- Business address
- 225 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
- 4 Shares withheld for taxes Head of Glob Prod Strat & Com gave up 2,342 shares (to pay taxes)
- 4 Shares withheld for taxes Head of Alzheimer's Disease gave up 122 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 171 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 8,566 shares (to pay taxes)
- 4 Shares withheld for taxes Head of Pharm Ops and Tech gave up 92 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award EVP Pharmaceutical Oper & Tech acquired 658 shares (grant or award)
- 4 Grant or award EVP, Human Resources acquired 1,941 shares (grant or award)
- 4 Grant or award Head of Glob Prod Strat & Com acquired 3,088 shares (grant or award)
- 4 Grant or award Chief Accounting Officer acquired 244 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 10,594 shares (grant or award)
- 4 Grant or award EVP Chief Legal Off & Corp Sec acquired 2,825 shares (grant or award)
Page 12 of 86 · 1,714 filings